BCRX icon

BioCryst Pharmaceuticals

258 hedge funds and large institutions have $1.26B invested in BioCryst Pharmaceuticals in 2024 Q4 according to their latest regulatory filings, with 35 funds opening new positions, 79 increasing their positions, 90 reducing their positions, and 32 closing their positions.

Holders
258
Holders Change
+2
Holders Change %
+0.78%
% of All Funds
3.44%
Holding in Top 10
5
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+25%
% of All Funds
0.07%
New
35
Increased
79
Reduced
90
Closed
32
Calls
$12.1M
Puts
$8.5M
Net Calls
+$3.61M
Net Calls Change
-$2.58M
Name Market Value Shares Shares
Change
Shares
Change %
WA
276
Waverly Advisors
Alabama
-19,713 Closed
SC
277
Scotia Capital
Ontario, Canada
-18,577 Closed
MF
278
Magnetar Financial
Illinois
-17,928 Closed
GVAG
279
Great Valley Advisor Group
Delaware
-16,400 Closed
NC
280
nVerses Capital
Florida
-15,500 Closed
GC
281
Guggenheim Capital
Illinois
-14,790 Closed
DTL
282
Dynamic Technology Lab
Singapore
-11,352 Closed
CPA
283
Capital Performance Advisors
California
-1,512 Closed
MIM
284
Macroview Investment Management
Maryland
-1,132 Closed
SSG
285
Summit Securities Group
New York
-412 Closed
QT
286
Quantbot Technologies
New York
-371 Closed
AF
287
Advisornet Financial
Minnesota
-259 Closed
Allspring Global Investments
288
Allspring Global Investments
North Carolina
-101 Closed
BTI
289
Blue Trust Inc
Georgia
-29 Closed
Wolverine Trading
290
Wolverine Trading
Illinois
GS
291
GTS Securities
New York
Simplex Trading
292
Simplex Trading
Illinois
VU
293
Valence8 US
Massachusetts
CFGS
294
Concourse Financial Group Securities
Alabama
Group One Trading
295
Group One Trading
Illinois
C
296
Covestor
United Kingdom
$0 17 +1 +6%